Genome Editor: AsCas12a (IDT and Feldan Therapeutics)
Summary
| SCGE ID | 11000000119 |
| Symbol | AsCas12a (IDT and Feldan Therapeutics) |
| Species | Acidaminococcus sp. BV3L6 |
| Type | Cas Nuclease |
| Subtype | AsCas12a (Cpf1) |
| Alias | AsCpf1 |
| Activity | Double strand cleavage |
| Substrate | double stranded DNA |
| DSB Cleavage Type | 5-bp Staggered DNA Double-strand Break Ends |
| PAM | 3' TTTV |
| Fusion | NLS |
| Source | IDT and Feldan Therapeutics |
Associated Publications |
| Publication Title |
|---|
| Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia. NCBI |
Projects & Experiments
This Genome Editor: AsCas12a (IDT and Feldan Therapeutics) is being used ...| Project | Initiative | Contact PI | |
|---|---|---|---|
| Delivery Systems |
Paul B McCray, Jr, MD
(University of Iowa) |
|